Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

Diabetes Drug Chart

Drug Action Use Side Effects Nursing Implications


-teach proper monitoring and
-stimulates glucose uptake by fat -used for Type 1 diabetes -metabolic derangements w/ management of blood sugar levels
and muscle cells -used for Type 2 diabetes, inadequate therapy— -teach S/Sx of hypo/hyperglycemia
Insulin -promotes glycogen formation in not controlled by diet ketoacidosis or -rotate injection sites
liver & muscle cells and/or oral hypoglycemics hypoglycemic coma DDIs: moderate to high alcohol
Lispro-rapid acting -lipoatrophy at injection consumption inc. hypoglycemic action of
Regular-short acting sites insulin
NPH-intermediate acting -allergies -beta-adrenergic agents or corticosteroids
Ultralente-long acting may antagonize actions of insulin and
mask hypoglycemic state

-blocks K channel in the -for Type 2 diabetics -GI distress -not to be used w/ renal or liver impaired
Sulfonylureas membrane of pancreatic ß cells; -dizziness, drowsiness, HA patients
depolarizes cell & stimulates 2nd generation: -allergies—skin rxs DDIs: sulfonamides, salicylates,
Incr.

1st gen: tolbutamide (ORINASE) release of insulin -fewer side effects -hypoglycemia phenylbutazon : hypoglycemia
nd
2 gen: glipizide -may also decr. hepatic glucose -more predictable action times &
-weight gain -thiazides: hyperglycemic activity
(GLUCOTROL) half-lives
production (glyconolysis and -fewer DDIs-bind to proteins -beta-adrenergic blocking agents
INSULIN

gluconeogenesis) and incr. tissue differently -disulfiram-like rx or possible


responsiveness to insulin -more expensive hypoglycemia w/ alcohol

Insulin Enhancers -promotes insulin secretion by the -for type 2 diabetics -hypoglycemia -patients must eat w/i 30 minutes of
pancreas administration
Repanglinide, (PRANDIN)
SECRETION

-stimulates insulin secretion by - Give 1-30 minutes before meals


-used alone or in combo -GI: same as metformin
pancreas - Category C: do not use during
therapy w/ Metformin or
Nateglinide (STARLIX) - extent of insulin release is glucose
Glyburide
pregnancy
dependent (‘smart drug’) - Avoid in patients w/ severe liver insuff
-for type 2 diabetes
- Works more quickly than Prandin

- decr. hepatic glucose -for treatment of type 2 -GI effects—anorexia, -Avoid in patients w/ severe liver or
Decr. Glucose production

production diabetes, alone or w/ a flatulence, metallic taste, renal dx, cardiorespiratory insufficiency,
Biguanides - incr. peripheral insulin sulfonylurea N/V, stomach pain, weight CHF
sensitivity esp. in muscle tissue -does not cause loss DDIs: avoid alcohol—hypoglycemic
Metformin hypoglycemia-an - Weight loss cimetidine, digoxin, morphine, rantidine,
(GLUCOPHAGE) antihyperglycemic drug - Decr. absorption of trimethorprim, furosemide,
vitamin B12 and folic acid vancomycin—incr. blood concentration
of metformin

-prolongs digestion of CHO -for treatment of type 2 -GI: flatulence, abdominal -used as mono or combo therapy w/
Stop Gut N-Zymes

Alpha-glucosidase -decr. peak plasma glucose levels diabetes pain, distenion, diarrhea, sulfonylureas
inhibitors by inhibiting intestinal enzymes borborygmi -TID w/ first bite of food
in SI that break complex -Incr. in liver enzymes -SE diminish w/ time—usually 3 wks
aka “starch-blockers”
acarabose (PRECOSE)
miglitol (GLYSET) carbohydrates into smaller DDIs: corticosteroids & thiazides—
molecules interfere w/ control of hyperglycemia
Drug Action Use Side Effects Nursing Implications
Decr. insulin resistance

-acts on target tissues to decr. insulin -for treatment of type 2 -edema, weight gain -cytochrome P450 inducer so check
Thiazolidinediones liver function: 1st six months-check
resistance in skeletal muscle diabetes; mono or combo -anemia
(Glitazones) monthly; 2nd six months-check
-may also decr. glucose output by the therapy
rosiglitazone (AVANDIA) liver every 2 months
pioglitazone (ACTOS) -teach patient of liver failure signs
DDIs: Ca channel blocking agents
corticosteroids, statins and BC pills

BLOOD GLUCOSE
LOWERING EFFECTS

Glucose Lowering Effect Glucose Raising Effect


Acetaminophen
Alcohol Beta-adrenergic blockers
Allopurinol Birth control pills
Aspirin (large doses) Cholestryramine (Questran)
Alpha-glucosidase inhibitors Corticosteroids
Beta-adrenergic blockers Ethacrynic acid
Biguanides Morphine
Clofibrate Epinephrine
Histamine antagonists Furosemide (LASIX)
Insulin Glucagons
MOA inhibitors Lithium
Probenecid Nicotine
Sulfonylureas Nifedipine
Troglitazone Phenobarbital
Tricyclic antidepressants Pnenothiazines
Urinary acidifiers Phenytoin (DILANTIN)
Rifampin
Thiazide diuretics
Urinary alkalizing agents

You might also like